Polymyositis and dermatomyositis (PM/DM) are systemic autoimmune diseases with multiple organ involvements that manifest as muscular and cutaneous disorders, interstitial lung disease (ILD) and malignancies. However, information concerning the outcomes and associated factors for PM/DM patients who are hospitalized is limited.We retrospectively reviewed the medical charts of PM/DM patients admitted to a Chinese tertiary referral hospital (Peking Union Medical College Hospital, PUMCH) from 2008 to 2014. The deceased group included 63 patients who had "deceased discharge" status or were confirmed to have died within two weeks of hospital discharge. The demographic data, clinical manifestations, and direct causes of death were analyzed retrospe...
Background: Dermatomyositis (DM) and polymyositis (PM) are rare systemic autoimmune rheumatic diseas...
Objective: Pneumomediastinum (PnM), a rare complication of dermatomyositis and polymyositis (DM/PM),...
Background\ud Dermatomyositis (DM) and polymyositis (PM) are rare systemic autoimmun...
<div><p>Background</p><p>Polymyositis and dermatomyositis (PM/DM) are systemic autoimmune diseases w...
Patients with idiopathic inflammatory myopathies (IIMs) are sometimes complicated with life-threaten...
Patients with idiopathic inflammatory myopathies (IIMs) are sometimes complicated with life-threaten...
Objective: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Objective: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Objective: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Objective: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
OBJECTIVE: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Abstract Background Interstitial lung disease (ILD) is the principal cause of death in polymyositis/...
OBJECTIVE: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
OBJECTIVE: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
OBJECTIVE: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Background: Dermatomyositis (DM) and polymyositis (PM) are rare systemic autoimmune rheumatic diseas...
Objective: Pneumomediastinum (PnM), a rare complication of dermatomyositis and polymyositis (DM/PM),...
Background\ud Dermatomyositis (DM) and polymyositis (PM) are rare systemic autoimmun...
<div><p>Background</p><p>Polymyositis and dermatomyositis (PM/DM) are systemic autoimmune diseases w...
Patients with idiopathic inflammatory myopathies (IIMs) are sometimes complicated with life-threaten...
Patients with idiopathic inflammatory myopathies (IIMs) are sometimes complicated with life-threaten...
Objective: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Objective: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Objective: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Objective: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
OBJECTIVE: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Abstract Background Interstitial lung disease (ILD) is the principal cause of death in polymyositis/...
OBJECTIVE: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
OBJECTIVE: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
OBJECTIVE: To assess the long-term outcome in polymyositis (PM) and dermatomyositis (DM), with a par...
Background: Dermatomyositis (DM) and polymyositis (PM) are rare systemic autoimmune rheumatic diseas...
Objective: Pneumomediastinum (PnM), a rare complication of dermatomyositis and polymyositis (DM/PM),...
Background\ud Dermatomyositis (DM) and polymyositis (PM) are rare systemic autoimmun...